PubRank

Min-Han Tan

Author PubWeight™ 75.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Patterns of somatic mutation in human cancer genomes. Nature 2007 38.41
2 External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol 2013 3.19
3 Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol 2012 2.84
4 An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 2011 2.78
5 A molecular classification of papillary renal cell carcinoma. Cancer Res 2005 1.60
6 Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy. Cancer 2010 1.52
7 Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol 2011 1.38
8 Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem Biophys Res Commun 2006 1.25
9 Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. PLoS Genet 2008 1.20
10 Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet 2011 1.14
11 Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria. Cancer 2013 1.12
12 Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 2007 1.10
13 VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res 2010 0.98
14 Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab. Leuk Lymphoma 2008 0.98
15 Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cancer 2012 0.97
16 Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC. Cancer Lett 2008 0.96
17 The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients. Target Oncol 2013 0.95
18 Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 2004 0.93
19 Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation. Cancer Chemother Pharmacol 2013 0.89
20 Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma. Am J Clin Pathol 2005 0.85
21 8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort. Urol Oncol 2012 0.85
22 A unique case of spontaneous regression of metastatic papillary renal cell carcinoma: a case report. Cases J 2009 0.84
23 Gene expression profiling of renal cell carcinoma and clinical implications. Urology 2005 0.84
24 An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women. Acta Oncol 2010 0.84
25 Gastrointestinal stromal tumour in the elderly. Crit Rev Oncol Hematol 2008 0.82
26 Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification. Chin J Cancer 2011 0.81
27 Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups. Breast Cancer Res Treat 2014 0.80
28 Predictive models for the practical management of renal cell carcinoma. Nat Rev Urol 2012 0.79
29 Correction: The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma. PLoS One 2015 0.78
30 Race to report: are vascular endothelial growth factor genetic polymorphisms associated with outcome in advanced breast cancer patients treated with Paclitaxel plus bevacizumab? J Clin Oncol 2009 0.78
31 Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients. Chin J Cancer 2011 0.78
32 Microarray gene expression profiling using core biopsies of renal neoplasia. Am J Transl Res 2009 0.76
33 Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges. Expert Rev Mol Diagn 2015 0.76
34 Association of drug exposure with toxicity and clinical response in metastatic renal cell carcinoma patients receiving an attenuated dosing regimen of sunitinib. Target Oncol 2014 0.76
35 'Prechronous' metastasis in clear cell renal cell carcinoma: a case report. J Med Case Rep 2011 0.75
36 Association between being underweight and outcomes in breast cancer: alternative explanations. J Clin Oncol 2010 0.75
37 Exploring the benefits of early access to palliative care in advanced lung cancer: living better, living longer, or both? J Clin Oncol 2012 0.75
38 Corrigendum: Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity. Sci Rep 2017 0.75
39 Papillary renal cell carcinoma with metastatic laparoscopic port site and vaginal involvement: a case report. J Med Case Rep 2011 0.75
40 A multimodality approach to reversible paraneoplastic encephalitis associated with ovarian teratomas. Acta Oncol 2009 0.75
41 Outcomes of Dose-Attenuated Docetaxel in Asian Patients with Castrate-Resistant Prostate Cancer. Ann Acad Med Singapore 2017 0.75